Home » Stocks » SILK

Silk Road Medical, Inc. (SILK)

Stock Price: $63.23 USD 0.73 (1.16%)
Updated Jan 20, 2021 1:50 PM EST - Market open
Market Cap 2.12B
Revenue (ttm) 72.73M
Net Income (ttm) -38.90M
Shares Out 33.76M
EPS (ttm) -1.21
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 20
Last Price $63.23
Previous Close $62.50
Change ($) 0.73
Change (%) 1.16%
Day's Open 63.00
Day's Range 63.00 - 64.83
Day's Volume 70,251
52-Week Range 23.16 - 69.94

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 1 month ago

SUNNYVALE, Calif., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the co...

Business Wire - 1 month ago

LONDON--(BUSINESS WIRE)--Deep Pharma Intelligence names Nanox Imaging (NASDAQ:NNOX), TransMedics, Inc. (NASDAQ: TMDX), Outset Medical, Inc. (NASDAQ:OM), Eargo, Inc. (NASDAQ:EAR), and Silk Road...

Other stocks mentioned: EAR, NNOX, OM, TMDX
GlobeNewsWire - 1 month ago

SUNNYVALE, Calif., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the ap...

Seeking Alpha - 2 months ago

Silk Road Medical, Inc. (SILK) CEO Erica Rogers on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 2 months ago

Silk Road Medical (SILK) delivered earnings and revenue surprises of -10.71% and 6.93%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the...

Benzinga - 2 months ago

Shares of Silk Road Medical (NASDAQ:SILK) were flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share decreased 19.23% over the past year to (...

GlobeNewsWire - 2 months ago

SUNNYVALE, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financi...

GlobeNewsWire - 2 months ago

SUNNYVALE, Calif., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the co...

Zacks Investment Research - 2 months ago

Silk Road Medical (SILK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire - 2 months ago

SUNNYVALE, Calif., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it wil...

GlobeNewsWire - 3 months ago

SUNNYVALE, Calif., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that m...

GlobeNewsWire - 3 months ago

SUNNYVALE, Calif., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced tha...

GlobeNewsWire - 3 months ago

SUNNYVALE, Calif., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced tha...

Seeking Alpha - 4 months ago

For this report, we analyzed the portfolios of the 13 small-cap growth investment managers with the best 10-year performance records.

Other stocks mentioned: ALRM, AVLR, ETSY, EYE, FIVN, FRPT, IRTC, LITE, MIME, NTRA, PLMR, QTWO, SPSC
GlobeNewsWire - 4 months ago

SUNNYVALE, Calif., Sept. 04, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the...

GlobeNewsWire - 5 months ago

SUNNYVALE, Calif., Aug. 19, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that...

Seeking Alpha - 5 months ago

Silk Road Medical, Inc. (SILK) CEO Erica Rogers on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 5 months ago

Silk Road Medical (SILK) delivered earnings and revenue surprises of 15.79% and 70.94%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

GlobeNewsWire - 5 months ago

SUNNYVALE, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported finan...

Zacks Investment Research - 5 months ago

Silk Road Medical (SILK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire - 5 months ago

SUNNYVALE, Calif., July 23, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it w...

Investopedia - 5 months ago

While most attention in health care has been going to large pharma companies, the charts suggest opportunities in niche subsectors.

Other stocks mentioned: XHE, XHS
GlobeNewsWire - 6 months ago

SUNNYVALE, Calif., July 09, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that...

GlobeNewsWire - 6 months ago

New Guidelines Consistent with Silk Road Medical Certification Process

GlobeNewsWire - 7 months ago

SUNNYVALE, Calif., May 20, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact,...

GlobeNewsWire - 8 months ago

SUNNYVALE, Calif., May 08, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact,...

The Motley Fool - 8 months ago

Investors responded negatively to the medical device company's pricing of a public stock offering.

GlobeNewsWire - 8 months ago

SUNNYVALE, Calif. , May 05, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact...

GlobeNewsWire - 8 months ago

SUNNYVALE, Calif., May 05, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact,...

Seeking Alpha - 8 months ago

Silk Road Medical, Inc. (SILK) CEO Erica Rogers on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 8 months ago

Silk Road Medical (SILK) delivered earnings and revenue surprises of -3.23% and 16.87%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 8 months ago

Silk Road Medical (SILK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire - 9 months ago

SUNNYVALE, Calif., April 06, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today provided a co...

Seeking Alpha - 9 months ago

Silk Road Medical Seeks Continued Growth Amid High Operating Losses

GlobeNewsWire - 10 months ago

SUNNYVALE, Calif., March 05, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impac...

Seeking Alpha - 10 months ago

Silk Road Medical, Inc's (SILK) CEO Erica Rogers on Q4 2019 Results - Earnings Call Transcript

The Motley Fool - 11 months ago

Less than a year after it went public, should investors be excited about this stroke-prevention biotech?

Zacks Investment Research - 1 year ago

This year's IPOs performed impressively on the back of strong innovation and a solid balance sheet.

Other stocks mentioned: BYND, KRTX, TPTX, ZM
GlobeNewsWire - 1 year ago

SUNNYVALE, Calif., Dec. 17, 2019 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced th...

GlobeNewsWire - 1 year ago

Updated Results of TCAR Surveillance Project Presented at 2019 VEITHsymposium

Seeking Alpha - 1 year ago

Silk Road Medical: Brighter Days Ahead

The Motley Fool - 1 year ago

The stroke prevention specialist is growing rapidly and has a huge opportunity ahead of it. Should investors get on board?

Seeking Alpha - 1 year ago

Silk Road Medical, Inc (SILK) CEO Erica Rogers on Q3 2019 Results - Earnings Call Transcript

The Motley Fool - 1 year ago

This newly public company is growing at breakneck speed and has a massive opportunity ahead of it.

Seeking Alpha - 1 year ago

Silk Road Medical, Inc (SILK) CEO Erica Rogers on Q2 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Silk Road Medical, Inc. (SILK) CEO Erica Rogers on Q1 2019 Results - Earnings Call Transcript

Market Watch - 1 year ago

Shares of Silk Road Medical Inc. soared in their public debut Thursday, enough to pace all gainers on the major U.S.

Investors Business Daily - 1 year ago

Shares of the Silk Road Medical IPO jumped about 77% on the first day of trading, with an initial public offering that drew heavy interest from investors for the medical device company.

Benzinga - 1 year ago

Silk Road Medical Inc will hit the Nasdaq under ticker SILK on Thursday. Here’s what you should know before making a bid.

About SILK

Silk Road Medical operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products includes ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent with clinical data regarding lasting safety outcomes; ENHANCE Transcarotid Peripheral Access Kit for use i... [Read more...]

Industry
Medical Devices
IPO Date
Apr 4, 2019
CEO
Erica Rogers
Employees
224
Stock Exchange
NASDAQ
Ticker Symbol
SILK
Full Company Profile

Financial Performance

In 2019, SILK's revenue was $63.35 million, an increase of 83.33% compared to the previous year's $34.56 million. Losses were -$52.42 million, 39.3% more than in 2018.

Financial Statements

Analyst Forecasts

According to 7 analysts, the average rating for SILK stock is "Buy." The 12-month stock price forecast is 67.83, which is an increase of 7.28% from the latest price.

Price Target
$67.83
(7.28% upside)
Analyst Consensus: Buy